Failed study [Study As­sess­ment]

posted by Dr_Dan  – Germany, 2014-03-10 18:36 (4490 d 06:35 ago) – Posting: # 12584
Views: 11,940

❝ Could this also be argued in front of regulatory authorities?

IMHO this will not be possible. For sample size calculation you assume a formulation difference of <5%. In case of Cmax this holds true whereas in case of AUC the T/R ratio is >10%. You could demonstrate bioequivalence but as Helmut demonstrated you would need an unethical high number of subjects since the study have to be overpowered to get the desired result.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
152 visitors (0 registered, 152 guests [including 34 identified bots]).
Forum time: 02:11 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5